You are here: Industry Insights > Pfizer

News List

NKMax America Partners with Merck KGaA and Pfizer contractpharma
September 18, 2020
Will evaluate the safety and tolerability of SNK01 in combination with avelumab (BAVENCIO).
Pfizer, Biontech Propose Expansion of Pivotal COVID-19 Vaccine Trial americanpharmaceuticalreview
September 16, 2020
Pfizer and BioNTech have submitted an amended protocol to the U.S. Food and Drug Administration (FDA) to expand the enrollment of their Phase 3 pivotal COVID-19 vaccine trial to up to approximately 44,000 participants which also allows for the ...
Pfizer CentreOne Appoints General Manager contractpharma
September 15, 2020
Pfizer CentreOne, a global pharmaceutical CDMO embedded within Pfizer and a supplier of specialty APIs, has appointed Andrew Moore as general manager.
COVID-19 vaccine makers to prepare joint pledge for safety expresspharma
September 07, 2020
The companies would pledge to adhere to high scientific and ethical standards in the conduct of clinical studies and in their manufacturing processes.
Pfizer, BMS' Eliquis tops Xarelto, vitamin K drugs for site-specific bleeding risks in French real-world study fiercepharma
September 01, 2020
Pfizer and Bristol Myers Squibb's anticoagulant superstar Eliquis has raced out to blockbuster sales in recent years and a big-time lead over its its warfarin alternative competitors.
Gilead, AstraZeneca and Pfizer may be winners in race for COVID-19 therapeutics and vaccines: GlobalData expresspharma
August 31, 2020
More than 1,200 therapeutics and vaccines have entered the research and development (R&D) pipeline since January 2020, according to GlobalData, and that number grows every week.
Parexel, Pfizer Extend Long-Term Partnership contractpharma
August 28, 2020
Parexel will provide clinical development services via full-service, hybrid and functional service provider (FSP) models across all therapeutic areas.
Top Pharma & Biopharma Quarterly Results contractpharma
August 26, 2020
Pfizer: 2Q Revenues: $11.8 billion (-11%). 2Q Earnings: $3.4 billion (-32%). YTD Revenues: $23.8 billion (-10%). YTD Earnings: $6.8 billion (-24%)...
Financial Report, Pfizer contractpharma
August 13, 2020
Biopharma revenues were $9.8 billion, up 6% operationally, primarily driven by Vyndaqel.
Pfizer signs multi-year deal to manufacture Gilead’s remdesivir pharmaceutical-technology
August 11, 2020
Pfizer has entered into a multi-year agreement to manufacture and supply Gilead Science’s experimental antiviral drug remdesivir, for the treatment of Covid-19 patients.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page